Merck sues US, calling move to cut drug prices "extortion"

Merck argues that a US law meant to cut costs for the elderly and disabled violates the constitution in suit filed Tuesday.
Photo: Brendan Mcdermid/Reuters/Ritzau Scanpix
Photo: Brendan Mcdermid/Reuters/Ritzau Scanpix
By Nacha Cattan, bloomberg

Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug prices with pharmaceutical companies – a reform aimed at cutting costs for elderly and disabled Medicare patients that the health-care giant says is “tantamount to extortion.”

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading